MIST (Milestone Pharmaceuticals) Marketable Securities: $112.90 Mil (As of Mar. 2026)


MIST Milestone Pharmaceuticals Inc MIST
26 GF Score
Price $1.22
! 6 Warning Signs
View Full Analysis

What is Milestone Pharmaceuticals Marketable Securities?

Milestone Pharmaceuticals MIST -5.43% 26 Marketable Securities is $112.90 Mil as of Mar. 2026. GuruFocus rates MIST with a GF Score™ of 26/100. The stock has 6 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Milestone Pharmaceuticals's Marketable Securities for the quarter that ended in Mar. 2026 was $112.90 Mil.

Milestone Pharmaceuticals's annual Marketable Securities declined from Dec. 2023 ($52.24 Mil) to Dec. 2024 ($44.38 Mil) and declined from Dec. 2024 ($44.38 Mil) to Dec. 2025 ($32.91 Mil).

Milestone Pharmaceuticals  (NAS:MIST) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Milestone Pharmaceuticals Marketable Securities Related Terms

Milestone Pharmaceuticals Marketable Securities Historical Data

* Premium members only.

The historical data trend for Milestone Pharmaceuticals's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Milestone Pharmaceuticals Marketable Securities Chart

Milestone Pharmaceuticals Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only 0.00 56.95 52.24 44.38 32.91

Milestone Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.87 0.92 35.90 32.91 112.90
MIST
26GF Score
Milestone Pharmaceuticals Inc MIST
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Milestone Pharmaceuticals Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $112.90 Mil mean?
Milestone Pharmaceuticals (MIST) has a Marketable Securities of $112.90 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Milestone Pharmaceuticals and its competitors.
Is Milestone Pharmaceuticals' Marketable Securities too high?
Milestone Pharmaceuticals' current Marketable Securities is $112.90 Mil. Overall, Milestone Pharmaceuticals has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Milestone Pharmaceuticals' Marketable Securities compare to TNYA and TLSA?
Milestone Pharmaceuticals' Marketable Securities of $112.90 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Milestone Pharmaceuticals and its competitors. Milestone Pharmaceuticals's current Marketable Securities is $112.90 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Milestone Pharmaceuticals stock overvalued right now?
Milestone Pharmaceuticals (MIST) has a current Marketable Securities of $112.90 Mil. The current Marketable Securities is $112.90 Mil. Milestone Pharmaceuticals' overall GF Score™ is 26/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Milestone Pharmaceuticals (MIST), the current Marketable Securities is $112.90 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Milestone Pharmaceuticals Business Description

Address 1111 Dr. Frederik-Phillips Boulevard, Suite 420, Montreal, QC, CAN, H4M 2X6
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
26GF Score

Get the complete analysis for MIST

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.22
Price